Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Non-Current Deffered Revenue (2017 - 2020)

CV Sciences' Non-Current Deffered Revenue history spans 3 years, with the latest figure at $1.5 million for Q4 2020.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $1.5 million in Q4 2020 year-over-year; TTM through Dec 2020 was $1.5 million, a N/A change, with the full-year FY2020 number at $1.5 million, changed N/A from a year prior.
  • Non-Current Deffered Revenue hit $1.5 million in Q4 2020 for CV Sciences, up from $1.3 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for CVSI hit a ceiling of $1.5 million in Q4 2020 and a floor of $1.1 million in Q4 2017.
  • Historically, Non-Current Deffered Revenue has averaged $1.3 million across 3 years, with a median of $1.3 million in 2018.
  • The widest YoY moves for Non-Current Deffered Revenue: up 24.44% in 2018, down 24.44% in 2018.
  • Tracing CVSI's Non-Current Deffered Revenue over 3 years: stood at $1.1 million in 2017, then increased by 24.44% to $1.3 million in 2018, then grew by 9.33% to $1.5 million in 2020.
  • Business Quant data shows Non-Current Deffered Revenue for CVSI at $1.5 million in Q4 2020, $1.3 million in Q4 2018, and $1.1 million in Q4 2017.